tiprankstipranks
pc:exped

Expedition Therapeutics

Expedition Therapeutics is a biotechnology company focused on developing innovative therapies for serious inflammatory and respiratory diseases. Their lead program, EXPD-101, is a next-generation DPP1 inhibitor with the potential to be a first-in-class treatment for chronic obstructive pulmonary disease (COPD) and other neutrophil-driven diseases. The company leverages deep expertise in translational science and clinical development, aiming to improve patient outcomes through cutting-edge therapeutic solutions.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$165M
Total Amount Raised$165M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$165M
Latest Funding Amount$165M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 09, 2025
Series A
$165.00M

Investors

Investor Name
Funding Round

Related News and Analysis